FNY Investment Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86K Buy
+1,100
New +$88.7K 0.03% 345
2026
Q1
Sell
-9,000
Closed -$864K 970
2025
Q4
$864K Buy
9,000
+8,723
+3,149% +$847K 0.24% 96
2025
Q3
$26K Sell
277
-4,023
-94% -$370K 0.01% 637
2025
Q2
$374K Buy
+4,300
New +$365K 0.16% 144
2025
Q1
Sell
-2,400
Closed -$191K 882
2024
Q4
$191K Sell
2,400
-1,400
-37% -$121K 0.1% 186
2024
Q3
$342K Buy
+3,800
New +$320K 0.16% 121
2024
Q1
Sell
-1,600
Closed -$131K 768
2023
Q4
$131K Buy
+1,600
New +$122K 0.15% 112
2022
Q2
Sell
-25
Closed -$2K 821
2022
Q1
$2K Buy
+25
New +$2.64K ﹤0.01% 627
2020
Q3
Sell
-400
Closed -$36K 563
2020
Q2
$36K Sell
400
-15,160
-97% -$1.45M 0.02% 227
2020
Q1
$1.4M Buy
+15,560
New +$1.66M 1.07% 22
2019
Q1
Sell
-418
Closed -$38K 840
2018
Q4
$38K Sell
418
-184
-31% -$17.2K 0.01% 275
2018
Q3
$59K Buy
+602
New +$55.7K 0.01% 345

Other funds holding MDT

FNY Investment Advisers's MDT Position: Q2 2026 in Review

FNY Investment Advisers opened a new position in Medtronic (MDT) in Q2 2026: 1,100 shares worth $86K. The stake represents 0.03% of the portfolio and ranks #345 among its holdings. This is a return to the name: FNY Investment Advisers previously reported a position in MDT as recently as Q4 2025.

FNY Investment Advisers first reported a position in MDT in Q3 2018 and has held it in 12 quarters since. The position peaked at $1.4M in Q1 2020. 1,235 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • FNY Investment Advisers held 1,100 shares of Medtronic worth $86K as of Q2 2026.
  • Medtronic was a new FNY Investment Advisers position in Q2 2026.
  • Medtronic made up 0.03% of FNY Investment Advisers's portfolio in Q2 2026, its #345 holding.
  • FNY Investment Advisers first reported a position in Medtronic in Q3 2018 and has held it in 12 quarters since.
  • FNY Investment Advisers's Medtronic position peaked at $1.4M in Q1 2020.
  • 1,235 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.